Literature DB >> 34104436

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.

Kevin Y Wang1, James Newman2, Chung-Shien Lee3, Nagashree Seetharamu2.   

Abstract

Breast cancer is the most common malignancy in women, and lung cancer, the leading cause of cancer-related mortality in the United States, is the most common subsequent primary cancer among breast cancer survivors. In this review, we examine the risk factors that cause subsequent primary lung cancer after breast cancer (referred to herein as BCLC patients) as well as the prognostic factors that may affect survival. Notable clinicopathological features include patient characteristics such as age, smoking history, and the presence of EGFR or BRCA mutations, as well as factors related to the treatment of breast cancer such as radiation, surgery, chemotherapy, stage, anti-estrogen therapy, and ER/PR/HER2 status.
© The Author(s) 2021.

Entities:  

Keywords:  BRCA; Breast cancer; EGFR; HER2 receptor; TP53; chemotherapy; estrogen receptor (ER); lung cancer; progesterone receptor (PR); radiation; surgery

Year:  2021        PMID: 34104436      PMCID: PMC8155786          DOI: 10.1177/20503121211017757

Source DB:  PubMed          Journal:  SAGE Open Med        ISSN: 2050-3121


  46 in total

1.  Targeting the estrogen pathway for the treatment and prevention of lung cancer.

Authors:  Timothy F Burns; Laura P Stabile
Journal:  Lung Cancer Manag       Date:  2014-02-01

Review 2.  Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients.

Authors:  Trine Grantzau; Jens Overgaard
Journal:  Radiother Oncol       Date:  2016-09-14       Impact factor: 6.280

3.  Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Authors:  Carolyn Taylor; Candace Correa; Frances K Duane; Marianne C Aznar; Stewart J Anderson; Jonas Bergh; David Dodwell; Marianne Ewertz; Richard Gray; Reshma Jagsi; Lori Pierce; Kathleen I Pritchard; Sandra Swain; Zhe Wang; Yaochen Wang; Tim Whelan; Richard Peto; Paul McGale
Journal:  J Clin Oncol       Date:  2017-03-20       Impact factor: 44.544

4.  Cancer treatment and survivorship statistics, 2019.

Authors:  Kimberly D Miller; Leticia Nogueira; Angela B Mariotto; Julia H Rowland; K Robin Yabroff; Catherine M Alfano; Ahmedin Jemal; Joan L Kramer; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-06-11       Impact factor: 508.702

5.  Lung cancer mortality risk among breast cancer patients treated with anti-estrogens.

Authors:  Christine Bouchardy; Simone Benhamou; Robin Schaffar; Helena M Verkooijen; Gerald Fioretta; Hyma Schubert; Vincent Vinh-Hung; Jean-Charles Soria; Georges Vlastos; Elisabetta Rapiti
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

6.  A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.

Authors:  Teresa Moran; Vanesa Quiroga; Beatriz Cirauqui; Laia Vila; Maria Gil-Moreno; Enric Carcereny; Mireia Margeli; Ana Muñoz-Marmol; Jose Luis Mate; Jose Maria Velarde; Miguel Angel Molina; Rafael Rosell
Journal:  Oncol Res Treat       Date:  2019-02-23       Impact factor: 2.825

7.  The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.

Authors:  Sara J Schonfeld; Rochelle E Curtis; William F Anderson; Amy Berrington de González
Journal:  Cancer Causes Control       Date:  2012-08-24       Impact factor: 2.506

8.  Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  Trine Grantzau; Lene Mellemkjær; Jens Overgaard
Journal:  Radiother Oncol       Date:  2013-02-08       Impact factor: 6.280

9.  A population-based analysis of secondary malignancies in breast cancer patients receiving breast reconstruction.

Authors:  Rene Warschkow; Thomas Cerny; Bruno M Schmied; Ulrich Güller; Beat Thuerlimann; Markus Joerger
Journal:  Br J Cancer       Date:  2016-05-17       Impact factor: 7.640

10.  Problems to affect long-term survival for breast cancer patients: An observational study of subsequent lung/bronchus malignancies.

Authors:  Jieqiong Liu; Zheyu Hu; Yuhua Feng; Shan Zeng; Meizuo Zhong
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.